
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20485011
[patent_doc_number] => 20260021209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-22
[patent_title] => SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 19/340137
[patent_app_country] => US
[patent_app_date] => 2025-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19340137
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/340137 | SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS | Sep 24, 2025 | Pending |
Array
(
[id] => 20287254
[patent_doc_number] => 20250312497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => METHOD OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 19/240908
[patent_app_country] => US
[patent_app_date] => 2025-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19240908
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/240908 | METHOD OF TREATING PROSTATE CANCER | Jun 16, 2025 | Pending |
Array
(
[id] => 20246951
[patent_doc_number] => 20250295820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 19/231931
[patent_app_country] => US
[patent_app_date] => 2025-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19231931
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/231931 | Stable, concentrated radionuclide complex solutions | Jun 8, 2025 | Pending |
Array
(
[id] => 20218722
[patent_doc_number] => 20250281653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => METHODS FOR TREATING PROSTATE CANCER WITH RADIOPHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 19/210753
[patent_app_country] => US
[patent_app_date] => 2025-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19210753
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/210753 | METHODS FOR TREATING PROSTATE CANCER WITH RADIOPHARMACEUTICALS | May 15, 2025 | Pending |
Array
(
[id] => 20444079
[patent_doc_number] => 20260000793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => MYOCARDITIS-TARGETED RADIONUCLIDE MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/202402
[patent_app_country] => US
[patent_app_date] => 2025-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19202402
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/202402 | MYOCARDITIS-TARGETED RADIONUCLIDE MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | May 7, 2025 | Pending |
Array
(
[id] => 20120534
[patent_doc_number] => 20250235565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
[patent_app_type] => utility
[patent_app_number] => 19/172114
[patent_app_country] => US
[patent_app_date] => 2025-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19172114
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/172114 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Apr 6, 2025 | Pending |
Array
(
[id] => 20083798
[patent_doc_number] => 20250213734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 19/084265
[patent_app_country] => US
[patent_app_date] => 2025-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19084265
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/084265 | Stable, concentrated radionuclide complex solutions | Mar 18, 2025 | Pending |
Array
(
[id] => 20048406
[patent_doc_number] => 20250186628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
[patent_app_type] => utility
[patent_app_number] => 18/990863
[patent_app_country] => US
[patent_app_date] => 2024-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18990863
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Dec 19, 2024 | Pending |
Array
(
[id] => 20048116
[patent_doc_number] => 20250186338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => Stable Soft Chews, and Methods to Produce Same
[patent_app_type] => utility
[patent_app_number] => 18/969629
[patent_app_country] => US
[patent_app_date] => 2024-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18969629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/969629 | Stable Soft Chews, and Methods to Produce Same | Dec 4, 2024 | Pending |
Array
(
[id] => 19990007
[patent_doc_number] => 20250128229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => PARTICLE-CONTAINING DROPLET SYSTEMS WITH MONODISPERSE FLUID VOLUMES
[patent_app_type] => utility
[patent_app_number] => 18/959449
[patent_app_country] => US
[patent_app_date] => 2024-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18959449
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/959449 | PARTICLE-CONTAINING DROPLET SYSTEMS WITH MONODISPERSE FLUID VOLUMES | Nov 24, 2024 | Pending |
Array
(
[id] => 19831005
[patent_doc_number] => 20250082791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/927058
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927058 | Stable, concentrated radionuclide complex solutions | Oct 24, 2024 | Issued |
Array
(
[id] => 20226363
[patent_doc_number] => 12415003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/927047
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10521
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927047
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927047 | Stable, concentrated radionuclide complex solutions | Oct 24, 2024 | Issued |
Array
(
[id] => 19768543
[patent_doc_number] => 20250049969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/927034
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927034
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927034 | Stable, concentrated radionuclide complex solutions | Oct 24, 2024 | Abandoned |
Array
(
[id] => 19744083
[patent_doc_number] => 20250032648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => Near-Infrared Dyes And Conjugates For Targeting Tumors
[patent_app_type] => utility
[patent_app_number] => 18/909354
[patent_app_country] => US
[patent_app_date] => 2024-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18909354
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/909354 | Near-Infrared Dyes And Conjugates For Targeting Tumors | Oct 7, 2024 | Pending |
Array
(
[id] => 19860848
[patent_doc_number] => 20250099634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/819282
[patent_app_country] => US
[patent_app_date] => 2024-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18819282
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/819282 | METHOD OF TREATING CANCER | Aug 28, 2024 | Abandoned |
Array
(
[id] => 19637467
[patent_doc_number] => 12168063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/640917
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14092
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640917 | Stable, concentrated radionuclide complex solutions | Apr 18, 2024 | Issued |
Array
(
[id] => 19578791
[patent_doc_number] => 12144873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/640891
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14039
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640891 | Stable, concentrated radionuclide complex solutions | Apr 18, 2024 | Issued |
Array
(
[id] => 19593185
[patent_doc_number] => 12151003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/640884
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14049
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640884 | Stable, concentrated radionuclide complex solutions | Apr 18, 2024 | Issued |
Array
(
[id] => 19622940
[patent_doc_number] => 12161732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 18/640907
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14047
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640907
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640907 | Stable, concentrated radionuclide complex solutions | Apr 18, 2024 | Issued |
Array
(
[id] => 20308083
[patent_doc_number] => 20250325712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/641097
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641097
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/641097 | TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR | Apr 18, 2024 | Pending |